Abstract Handgrip strength is a strong indicator of total body muscle strength and is a predictor of poor outcomes in older adults. The aging suppressor gene klotho encodes a single-pass transmembrane protein that is secreted as a circulating hormone. In mice, disruption of klotho expression results in a syndrome that includes sarcopenia, atherosclerosis, osteoporosis, and shortened lifespan, and conversely, overexpression of klotho leads to a greater longevity. The objective was to determine whether plasma klotho levels are related to skeletal muscle strength in humans. We measured plasma klotho in 804 adults,¸65 years, in the InCHI-ANTI study, a longitudinal population-based study of aging in Tuscany, Italy. Grip strength was positively correlated with plasma klotho at threshold <681 pg/mL. After adjusting for age, sex, education, smoking, physical activity, cognition, and chronic diseases, plasma klotho (per 1 standard deviation increase) was associated with grip strength (beta = 1.20, standard error = 0.35, P = 0.0009) in adults with plasma klotho <681 pg/mL. These results suggest that older adults with lower plasma klotho have poor skeletal muscle strength.
Introduction
Aging is accompanied by sarcopenia, deWned as the loss of skeletal muscle mass and muscle strength (Morley et al. 2001) . Humans lose »20-40% of both skeletal muscle mass and strength from 20 to 80 years of age (Carmeli et al. 2002; Doherty 2003) . Poor skeletal muscle strength is predictive of disability (Giampaoli et al. 1999; Rantanen et al. 1999 ) and mortality (Rantanen et al. 2003) . Handgrip strength is strongly correlated with other measures of muscle strength and is often considered representative of total body muscle strength (Rantanen et al. 2003) . Among the many underlying causes of sarcopenia are increased oxidative stress and inXammation, hormonal changes, anorexia of aging, and lack of physical activity (Doherty 2003) .
Klotho, a recently discovered hormone, may play a potential role in the pathogenesis of sarcopenia. The aging suppressor gene klotho encodes a single-pass transmembrane protein that is predominantly expressed in the distal tubule cells of the kidney, parathyroid glands, and choroid plexus of the brain. The klotho gene was named after one of the three Fates in Greek mythology, the goddess who spins the thread of life. Klotho was originally identiWed in a mutant mouse strain that could not express klotho, developed multiple disorders resembling human aging, and had a shortened life span (Kuro-o et al. 1997) . The aging phenotypes included atherosclerosis, endothelial dysfunction, decreased bone mineral density, sarcopenia, skin atrophy, and impaired cognition (Iida et al. 2011; Kuro-o 2010; Saito et al. 1998) .
In vivo gene delivery of klotho has been shown to protect against endothelial dysfunction in an atherosclerotic mouse model (Saito et al. 2000) and hypertension and renal damage in a hypertensive rat model (Wang and Sun 2009) . Overexpression of klotho in transgenic mice resulted in a signiWcant extension of life span compared with wild-type mice (Kurosu et al. 2005) . These Wndings suggest that some phenotypes of aging may be ameliorated and lifespan increased by increased expression of klotho.
There are two forms of klotho, membrane and secreted, and each has diVerent functions. Membrane klotho acts as an obligate co-receptor for Wbroblast growth factor (FGF)-23, a bone-derived hormone that induces phosphate excretion into urine (Urakawa et al. 2006) . Secreted klotho is involved in regulation of nitric oxide production in the endothelium (Saito et al. 1998 (Saito et al. ,2000 , calcium homeostasis in the kidney (Chang et al. 2005; Imura et al. 2004 ), inhibition of intracellular insulin and insulin-like growth factor-1 signaling (Kurosu et al. 2005) , and inhibition of transforming growth factor-1 signaling (Doi et al. 2011) . Klotho gene transcripts for a putative secreted form of klotho protein were described in 1998 . In 2004, Imura and colleagues demonstrated that klotho protein was present in both human sera and cerebrospinal Xuid (Imura et al. 2004) . The relationship of circulating klotho with clinical phenotypes in human aging has not been studied because of the lack of a sensitive and reliable assay for measurement of secreted klotho protein in the blood. For example, it is not known whether low plasma klotho levels are associated with poor muscle strength in humans. Recently, a sensitive and speciWc assay was developed for the measurement of soluble klotho in humans (Yamazaki et al. 2010) .
We hypothesized that low plasma klotho concentrations were independently associated with skeletal muscle strength. To address this hypothesis, we measured plasma klotho levels in a large, population-based study of aging.
Materials and methods
The study participants consisted of men and women, aged 65 and older, who participated in the Invecchiare in Chianti, "Aging in the Chianti Area" (InCHIANTI) study, conducted in two small towns in Tuscany, Italy. The rationale, design, and data collection have been described elsewhere, and the main outcome of this longitudinal study is mobility disability (Ferrucci et al. 2000) . BrieXy, in August 1998, 1,270 people aged 65 years and older were randomly selected from the population registry of Greve in Chianti (pop. 11,709) Participants were evaluated again for a 3-year follow-up visit from 2001-2003 (n = 926) and 6-year follow-up visit from 2004-2006 (n = 844) , and 9-year follow-up visit from 2007-2009 (n = 768) . Of the 926 participants seen at the 3-year follow-up visit, 804 (86.8%) had blood drawn and plasma available for analysis. There were no signiWcant diVerences in age, sex, other demographic factors, or subsequent mortality between those who did or did not participate in the blood drawing. Plasma klotho was measured at the 3-year follow-up visit and not the enrollment visit because of the greater availability of archived plasma samples from the 3-year visit. The 3-year visit will be referred to as the baseline visit for the present study of klotho and grip strength. There were 775 participants who had measurements of both plasma klotho and grip strength at baseline, and of these, grip strength measurements were available on 608 participants at the 6-year visit and 472 participants at the 9-year visit.
Demographic information and information on smoking and medication use were collected using standardized questionnaires. Smoking history was determined from selfreport. Daily alcohol intake, expressed in gm/day, was determined based upon the European Prospective Investigation into Cancer and Nutrition food frequency questionnaire that had been validated in the Italian population. Education was recorded as years of school.
All participants were examined by a trained geriatrician. Diseases were ascertained according to standard, preestablished criteria and algorithms based upon those used in the Women's Health and Aging Study for diabetes mellitus, coronary heart disease, chronic heart failure, stroke, and cancer (Guralnik et al. 1995) . Those who did not have diabetes by the algorithm but had a fasting plasma glucose >125 mg/dL (American Diabetes Association 2006) were also considered to have diabetes.
Systolic and diastolic blood pressures were calculated from the mean of three measures taken with a standard mercury sphygmomanometer during the physical examination. Weight was measured using a high-precision mechanical scale. Standing height was measured to the nearest 0.1 cm. Body mass index (BMI) was calculated as weight/height 2 (kg/m 2 ). Mini-Mental State Examination (MMSE) was administered at enrollment, and an MMSE score <24 was considered consistent with cognitive impairment (Folstein et al. 1975) . Chronic kidney disease was deWned as estimated glomerular Wltration rate of <60 mL/min/1.73 m 2 using the four-variable ModiWcation of Diet in Renal Disease Study equation of Levey and colleagues (Levey et al. 1999) .
Grip strength was measured with a Jamar dynamometer (Irvington, NY). Before testing, the examiner asked the subject if he/she had pain in one hand or in both (for example, a new acute phase of an arthrosis process or a recent attack of gout), or if he had undergone any surgery to the hand. If the response was aYrmative, the aVected limb was not tested; if both hands were aVected, the test was deferred. The subject was seated in front of a bench with the arm of the test hand supported on the bench with the elbow Xexed to 45 degrees. The examiner adjusted the handle of the dynamometer such that the proximal interphalangeal joints of the hand were bent to 90 degrees. The examiner asked the subject to perform a practice test and said: 'Try once to use the device to understand how it works. Squeeze the handle until your hand is closed. It does not matter whether you use your maximum strength. Instead, tell me whether you feel you are in a comfortable position to carry out the task.' The examiner then adjusted the device, if necessary, and started the test saying: 'Now begin the test. When I say go, begin to squeeze with all your might. You are ready. Squeeze. Fine, just relax.' The test lasted about 5 s and two sessions were performed. Both hands were tested, unless contraindicated as above.
Grip strength is a strong predictor of mortality (Rantanen et al. 1999) , thus, the competing risk of mortality was also taken into account in this analysis. At the end of the Weld data collection, mortality data of the original InCHIANTI cohort were collected using data from the Mortality General Registry maintained by the Tuscany Region. Analyses include those who refused to participate in the follow-up after baseline or those who moved away but were known to be alive at the time of censoring of this analysis.
Blood samples were collected in the morning after a 12-h fast. Aliquots of serum and plasma were immediately obtained and stored at ¡80°C. Soluble -klotho was measured in EDTA-plasma using a solid phase sandwich enzyme-linked immunosorbent assay (ELISA) (ImmunoBiological Laboratories, Takasaki, Japan) (Yamazaki et al. 2010) . The minimum level of detectability of the assay is 6.15 pg/mL. The minimum level is below the plasma concentrations that were found in our study. The intra-and inter-assay coeYcients of variation were 4.1 and 8.9% for klotho measurements in the investigator's (R.D.S.) laboratory. The designation -klotho is used to describe the original klotho gene and its product (Imura et al. 2007 ) and to distinguish it from a homolog which was named -klotho (Ito et al. 2000) . Throughout this paper, the term klotho refers to -klotho. Commercial enzymatic tests (Roche Diagnostics) were used for measuring serum total cholesterol, triglycerides, and high-density lipoprotein (HDL) cholesterol concentrations. Low-density lipoprotein (LDL) cholesterol was calculated by the Friedewald formula (Friedewald et al. 1972) .
Variables are reported as medians (25th, 75th percentiles) or as percentages. An exploratory analysis using scatterplots and lowess smoothing curves suggested a threshold between plasma klotho and grip strength. Nonparametric deviance reduction (Qian et al. 2003 ) was used to identify the threshold of 681 pg/mL of plasma klotho in relation to grip strength. Given the threshold of plasma klotho, we used piecewise regression (McGee and Willard 1970) to examine the relationship between plasma klotho and grip strength at the 3(baseline), 6, and 9-year follow-up visits. In multivariable linear mixed models, no signiWcant plasma klotho and time interactions were found in the individual models. All analyses were performed using SAS (v. 9.1.3, SAS Institute, Inc., Cary, NC) with a type I error of 0.05.
Results
The baseline characteristics of the participants are shown in Table 1 . The relationship between plasma klotho and grip strength is shown in Fig. 1 . As noted in the Methods, nonparametric deviance reduction was used to identify a threshold relationship between plasma klotho and grip strength at baseline of 681 pg/mL. The proportion of participants who were above and below the threshold was 46.8 and 53.2%, respectively. Univariate linear regression models were used to examine the relationship between participant characteristics and grip strength at baseline (Table 2) . Piecewise regression was used to examine the relationship between plasma klotho, above and below 681 pg/mL, with grip strength at baseline. Older age, physical inactivity, cognitive impairment, congestive heart failure, stroke, chronic obstructive pulmonary disease, chronic kidney disease, depression, cancer, and plasma klotho, per 1 SD increase, for participants¸681 pg/mL had signiWcant negative association with grip strength. Current smoking and plasma klotho, per 1 SD increase, for participants <681 pg/mL, were signiWcantly and positively associated with grip strength.
Multivariable linear mixed models using piecewise regression were used to examine the relationship between plasma klotho and other covariates with grip strength at baseline and at 3 and 6 years following the baseline visit (Table 3 ). In models adjusting for age and sex (model 1), additionally for education, smoking, and physical activity (model 2), and Wnally adding MMSE score, stroke, heart failure, chronic kidney disease, cancer, and depression, in participants with plasma klotho <681 pg/mL, an increase in plasma klotho was signiWcantly associated with increased grip strength (per 1 SD increase, beta = 1.20, standard error = 0.35, P = 0.0009). Plasma klotho¸681 pg/mL had no signiWcant relationship with grip strength once adjusted for other covariates in the three models above. Coronary artery disease (%) 6.1
Heart failure (%) 7.7
Peripheral artery disease (%) 13.7
Stroke (%) 7.6
Diabetes mellitus (%) 14.3
Cancer (%) 8.7
Chronic kidney disease (%) 28.6
Depression (%) 28.5 We examined the relationship between tertiles of plasma klotho (<575, 575-763, >763 pg/mL) and decline in grip strength over 6 years of follow-up. Mean (standard deviation) decline in grip strength from the lowest to the highest tertile of plasma klotho was 8.27 (4.83), 7.54 (5.04), and 7.25 (4.70) kg, respectively. In multivariable linear mixed models adjusting for age, sex, baseline grip strength, and other covariates above, tertile of plasma klotho at baseline was not signiWcantly associated with decline in grip strength (data not shown). The proportion of participants who died during 6 years of follow-up from lowest to the highest tertile of plasma klotho was 31.1, 24.2, and 17.1% (P < 0.0001). The mortality results from this cohort are being reported in detail in a separate paper.
Discussion
The present study shows that older community-dwelling adults with low plasma klotho concentrations have poor grip strength. To our knowledge, this is the Wrst study to describe the relationship between circulating klotho hormone and skeletal muscle strength in humans. The Wndings are consistent with sarcopenia that has been described in the klotho mouse model of aging (Iida et al. 2011; Kuro-o 2010) . Plasma klotho concentrations at baseline were associated with grip strength measurements measured during a 6 year study period. Although plasma klotho was not an independent predictor of decline in grip strength over 6 years of follow-up, there was a strong competing risk of mortality. Participants with low plasma klotho concentrations were at a higher risk of death, as described in greater detail in a separate paper (Semba et al. 2011) .
Sarcopenia is characterized by loss of skeletal muscle strength and muscle mass due to enhanced catabolic activity in muscle. Two major pathways are involved in the catabolism of protein in muscle cells. In the autophagiclysosomal pathway, macromolecules and organelles are absorbed into autophagosomes and degraded after fusion with lysosomes and subsequent lysosomal degradation (Mehrpour et al. 2010 ). In the ubiquitin-proteasomal pathway, proteins are conjugated to multiple ubiquitins and then degraded within the proteasome complex (Clague and Urbé 2010) . Insulin/insulin-like growth factor-1 (IGF-1) signaling regulates both pathways through Akt and FoxO3 in skeletal muscle (Glass 2003; Mammucari et al. 2007 ). Circulating klotho is believed to regulate insulin/IGF-1 signaling, but the biological mechanism has yet to be identiWed (Kuro-o 2010). A recent study suggests that the autophagic-lysosomal pathway is activated in mutant klotho mice, but there was no evidence for activation of the ubiquitin-proteasomal pathway or insulin/IGF-1 signaling in klotho mice (Iida et al. 2011) .
The strengths of the present study are that the participants were drawn from a population-based sample of older adults living in the community. Grip strength was carefully assessed using standardized methodology. Findings were based upon baseline and 6 years of follow-up data. Although the analyses were adjusted for potential confounders such as age and chronic diseases, as with any epidemiological study, there may be unmeasured confounding factors that could inXuence the relationship between plasma klotho and muscle strength. The study populations consisted of white adults from the rural Chianti region of Tuscany, Italy, and whether these Wndings can be extrapolated to populations in other parts of the world and to minorities is not known.
Future studies are needed to examine the relationship between circulating klotho and skeletal muscle mass and changes in skeletal muscle mass over time. 
